InfuSystem Holdings, Inc. (NYSEAMERICAN:INFU) Director Christopher R. Sansone Sells 40,000 Shares of Stock

InfuSystem Holdings, Inc. (NYSEAMERICAN:INFUGet Rating) Director Christopher R. Sansone sold 40,000 shares of the stock in a transaction on Monday, November 21st. The stock was sold at an average price of $8.06, for a total value of $322,400.00. Following the transaction, the director now directly owns 147,280 shares in the company, valued at approximately $1,187,076.80. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website.

InfuSystem Stock Performance

INFU opened at $8.23 on Tuesday. InfuSystem Holdings, Inc. has a twelve month low of $6.10 and a twelve month high of $18.35. The stock has a market cap of $170.00 million, a PE ratio of -274.33 and a beta of 1.18. The business’s 50 day moving average is $8.74 and its 200-day moving average is $9.12. The company has a current ratio of 1.59, a quick ratio of 1.25 and a debt-to-equity ratio of 0.72.

Analyst Upgrades and Downgrades

Separately, StockNews.com raised InfuSystem from a “buy” rating to a “strong-buy” rating in a research report on Wednesday, September 7th.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the business. Friess Associates LLC grew its position in InfuSystem by 51.6% during the 1st quarter. Friess Associates LLC now owns 246,293 shares of the medical instruments supplier’s stock worth $2,414,000 after purchasing an additional 83,845 shares in the last quarter. Greenwood Capital Associates LLC grew its position in InfuSystem by 19.0% during the 1st quarter. Greenwood Capital Associates LLC now owns 92,987 shares of the medical instruments supplier’s stock worth $911,000 after purchasing an additional 14,826 shares in the last quarter. Granite Point Capital Management L.P. acquired a new stake in shares of InfuSystem during the 1st quarter valued at $315,000. Heartland Advisors Inc. boosted its stake in shares of InfuSystem by 25.0% during the 1st quarter. Heartland Advisors Inc. now owns 250,000 shares of the medical instruments supplier’s stock valued at $2,450,000 after buying an additional 50,000 shares during the period. Finally, Cornercap Investment Counsel Inc. acquired a new stake in shares of InfuSystem during the 1st quarter valued at $508,000. Institutional investors and hedge funds own 54.51% of the company’s stock.

InfuSystem Company Profile

(Get Rating)

InfuSystem Holdings, Inc, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services). It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.

Further Reading

Insider Buying and Selling by Quarter for InfuSystem (NYSEAMERICAN:INFU)

Receive News & Ratings for InfuSystem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InfuSystem and related companies with MarketBeat.com's FREE daily email newsletter.